These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 34899855)

  • 1. RNA m6A Methylation Regulators Multi-Omics Analysis in Prostate Cancer.
    Su H; Wang Y; Li H
    Front Genet; 2021; 12():768041. PubMed ID: 34899855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and clinical prognostic value of m6A RNA methylation modification in breast cancer.
    Zheng F; Du F; Qian H; Zhao J; Wang X; Yue J; Hu N; Si Y; Xu B; Yuan P
    Biomark Res; 2021 Apr; 9(1):28. PubMed ID: 33926554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene Alterations of N6-Methyladenosine (m
    Zhang Q; Cai Y; Kurbatov V; Khan SA; Lu L; Zhang Y; Johnson CH
    Biomed Res Int; 2020; 2020():8826456. PubMed ID: 33415160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The functions and prognostic values of m6A RNA methylation regulators in thyroid carcinoma.
    Yu ZH; Feng ST; Zhang D; Cao XC; Yu Y; Wang X
    Cancer Cell Int; 2021 Jul; 21(1):385. PubMed ID: 34281544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
    Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
    Front Immunol; 2021; 12():669750. PubMed ID: 34054840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of a risk prediction model using m6A RNA methylation regulators in prostate cancer: comprehensive bioinformatic analysis and histological validation.
    Quan Y; Zhang X; Ping H
    Cancer Cell Int; 2022 Jan; 22(1):33. PubMed ID: 35045837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA m6a Methylation Regulator Expression in Castration-Resistant Prostate Cancer Progression and Its Genetic Associations.
    Liyanage C; Fernando A; Chamberlain A; Moradi A; Batra J
    Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38610981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune infiltration-related N6-methyladenosine RNA methylation regulators influence the malignancy and prognosis of endometrial cancer.
    Ma J; Yang D; Ma XX
    Aging (Albany NY); 2021 Jun; 13(12):16287-16315. PubMed ID: 34230220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive analysis of m6A regulators prognostic value in prostate cancer.
    Ji G; Huang C; He S; Gong Y; Song G; Li X; Zhou L
    Aging (Albany NY); 2020 Jul; 12(14):14863-14884. PubMed ID: 32710725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. m6A Regulators Is Differently Expressed and Correlated With Immune Response of Esophageal Cancer.
    Zhao H; Xu Y; Xie Y; Zhang L; Gao M; Li S; Wang F
    Front Cell Dev Biol; 2021; 9():650023. PubMed ID: 33748145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of m6A-related genes and m6A RNA methylation regulators in pancreatic cancer and their association with survival.
    Geng Y; Guan R; Hong W; Huang B; Liu P; Guo X; Hu S; Yu M; Hou B
    Ann Transl Med; 2020 Mar; 8(6):387. PubMed ID: 32355831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The methylation modification of m6A regulators contributes to the prognosis of ovarian cancer.
    Zhu W; Zhao L; Kong B; Liu Y; Zou X; Han T; Shi Y
    Ann Transl Med; 2022 Jan; 10(2):59. PubMed ID: 35282121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N6-Methyladenosine Regulators Promote Malignant Progression of Gastric Adenocarcinoma.
    Zhao Y; Yan X; Wang Y; Zhou J; Yu Y
    Front Oncol; 2021; 11():726018. PubMed ID: 35299934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pan-Cancer Prognostic, Immunity, Stemness, and Anticancer Drug Sensitivity Characterization of N6-Methyladenosine RNA Modification Regulators in Human Cancers.
    Li R; Yin YH; Ji XL; Liu X; Li JP; Qu YQ
    Front Mol Biosci; 2021; 8():644620. PubMed ID: 34150845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive Analysis of Expression Regulation for RNA m6A Regulators With Clinical Significance in Human Cancers.
    Liu X; Wang P; Teng X; Zhang Z; Song S
    Front Oncol; 2021; 11():624395. PubMed ID: 33718187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Characterization and Clinical Relevance of N
    Liu Q; Li Z; He L; Li K; Hu C; Chen J; Zhou F; Wang J; Li Y; Xiao H
    Front Oncol; 2022; 12():914692. PubMed ID: 35814454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of m6A-Related Signatures in the Tumor Immune Microenvironment and Identification of Clinical Prognostic Regulators in Adrenocortical Carcinoma.
    Jin Y; Wang Z; He D; Zhu Y; Hu X; Gong L; Xiao M; Chen X; Cheng Y; Cao K
    Front Immunol; 2021; 12():637933. PubMed ID: 33746977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Validation of an m6A RNA Methylation Regulators-Based Signature for Predicting the Prognosis of Adrenocortical Carcinoma.
    Shen C; Liu J; Yang X; Jiao W; Wang Y
    Front Endocrinol (Lausanne); 2021; 12():568397. PubMed ID: 33692753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Analysis of Regulatory Networks of m6A Regulators and Reveals Prognosis Biomarkers in Sarcoma.
    Pang B; Luo D; Cao B; Wu W; Wang L; Hao Y
    Front Oncol; 2022; 12():911596. PubMed ID: 35847857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. m6A RNA methylation regulators can contribute to malignant progression and impact the prognosis of bladder cancer.
    Chen M; Nie ZY; Wen XH; Gao YH; Cao H; Zhang SF
    Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31808521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.